Immunosuppressive effects of factor IX products: an in vitro study.

about

Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.Use of recombinant factor IX in subjects with haemophilia B undergoing surgery.

P2860

Q36473047-083A7C28-D4DF-4786-8B5A-0AF6930C6BE2 Q45885107-A432A314-05D0-4BAB-AFAF-0D45612C14BD

P2860

Immunosuppressive effects of factor IX products: an in vitro study.

Item

http://www.wikidata.org/entity/Q45863771

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Immunosuppressive effects of factor IX products: an in vitro study.

@en

Immunosuppressive effects of factor IX products: an in vitro study.

@nl

type

Item

label

Immunosuppressive effects of factor IX products: an in vitro study.

@en

Immunosuppressive effects of factor IX products: an in vitro study.

@nl

prefLabel

Immunosuppressive effects of factor IX products: an in vitro study.

@en

Immunosuppressive effects of factor IX products: an in vitro study.

@nl

P1476

Immunosuppressive effects of factor IX products: an in vitro study.

@en

P2093

Grosset AB

http://www.w3.org/2001/XMLSchema#string

McGregor JR

http://www.w3.org/2001/XMLSchema#string

Rodgers GM

http://www.w3.org/2001/XMLSchema#string

P2860

Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital

Blood transfusion and postoperative infections.

Why prescribe highly purified factor VIII and IX concentrates?

Immunosuppressive property of a very high purity antihaemophilic preparation: a low molecular weight component inhibits an early step of PHA induced cell activation.

T cell sensitization to factor VIII in haemophilia A?

Phenotypic and functional abnormalities in monocytes from patients with haemophilia A treated with factor VIII concentrates.

Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentrates.

Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.

Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacs.

Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection.

P304

416-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2516.1999.00343.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wolfram Samlowski

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10583529

http://www.w3.org/2001/XMLSchema#string

Immunosuppressive effects of factor IX products: an in vitro study.

about

P2860

P2860

Immunosuppressive effects of factor IX products: an in vitro study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698